Connection
Michael Szarek to Lipoproteins, VLDL
This is a "connection" page, showing publications Michael Szarek has written about Lipoproteins, VLDL.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.239 |
|
|
|
-
Inia JA, Zhang LH, Keijzer N, Worms N, van Nieuwkoop-van Straalen A, Ditmarsch M, de Kleer M, Jukema JW, Kastelein JJP, Szarek M, van den Hoek AM, Stokman G, Pieterman EJ, Princen HMG. Obicetrapib and ezetimibe enhance LDL receptor-mediated VLDL clearance and regress atherosclerosis on atorvastatin background. J Lipid Res. 2026 May; 67(5):101028.
Score: 0.239